Clene Inc. (CLNN) Financial Statements (2026 and earlier)

Company Profile

Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT 84121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:5,20012,20035,00023,30050,34659,275
Cash and cash equivalent5,18912,15528,82118,33250,34659,275
Short-term investments   6,1794,983  
Other undisclosed cash, cash equivalents, and short-term investments1145 (15)  
Receivables 6414318949 
Inventory, net of allowances, customer advances and progress billings3768374341191
Inventory3768374341191
Prepaid expense2,7361,8491,9092,290  
Other current assets139137568581  
Other undisclosed current assets8651,8391,1952,7924,1473,523
Total current assets:8,97716,15738,85229,19554,58362,989
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization  187187310  
Operating lease, right-of-use asset3,0733,6434,1684,6023,2501,029
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization     5,1724,225
Regulated entity, other noncurrent assets1,441     
Restricted cash and investments5858585858 
Other undisclosed noncurrent assets4,5827,2929,07610,328  
Total noncurrent assets:9,15411,18013,48915,2988,4805,254
TOTAL ASSETS:18,13127,33752,34144,49363,06368,243
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5,8949,0065,2246,8773,6103,960
Taxes payable✕✕✕✕✕ 164
Employee-related liabilities✕✕✕✕✕2,0821,258
Accounts payable8921,2401,5043,014 1,124
Accrued liabilities5,0027,7663,7203,863 3,960
Other undisclosed accounts payable and accrued liabilities     1,528(2,546)
Deferred revenue      112
Debt4,07435919,5306,4921466,114
Other undisclosed current liabilities8089265764882,2701,482
Total current liabilities:10,77610,29125,33013,8576,02611,668
Noncurrent Liabilities
Long-term debt and lease obligation3,74115,4261,8949,51718,9513,939
Long-term debt, excluding current maturities3,74115,4261,8949,48314,4841,949
Finance lease, liability    3497205
Liabilities, other than long-term debt3,2504,1326,3845,55718,100260
Deferred income tax liabilities      260
Operating lease, liability3,2504,1324,9035,5574,3701,785
Derivative instruments and hedges, liabilities   1,481 18,100 
Other undisclosed noncurrent liabilities17,9566,3455,34312,3257,38952,035
Total noncurrent liabilities:24,94725,90313,62127,39944,44056,234
Total liabilities:35,72336,19438,95141,25650,46667,902
Equity
Equity, attributable to parent(17,592)(8,857)13,3903,23712,597341
Common stock1113766
Additional paid in capital290,531273,194255,901196,246175,659153,571
Accumulated other comprehensive income17271199203233325
Accumulated deficit(308,296)(282,123)(242,723)(193,219)(163,301)(153,561)
Total equity:(17,592)(8,857)13,3903,23712,597341
TOTAL LIABILITIES AND EQUITY:18,13127,33752,34144,49363,06368,243

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues200342654473723206
Revenue from related parties✕✕✕✕460500 
Cost of revenue(43)(70)(121)(26)  
Gross profit:157272533447723206
Operating expenses(23,240)(33,365)(41,073)(48,856)(50,701)(20,420)
Operating loss:(23,083)(33,093)(40,540)(48,409)(49,978)(20,214)
Nonoperating income (expense)(3,090)(6,307)(8,964)18,49139,8101,343
Investment income, nonoperating2238651,389   
Interest and debt expense(2,682)(214)(4,558)(16)648(540)
Loss from continuing operations before equity method investments, income taxes:(28,855)(39,614)(54,062)(29,934)(9,520)(19,411)
Other undisclosed income (loss) from continuing operations before income taxes2,6822144,55816(648)540
Loss from continuing operations before income taxes:(26,173)(39,400)(49,504)(29,918)(10,168)(18,871)
Income tax expense (benefit)     428(406)
Loss from continuing operations:(26,173)(39,400)(49,504)(29,918)(9,740)(19,277)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(9,740)(19,277)
Net loss available to common stockholders, diluted:(26,173)(39,400)(49,504)(29,918)(9,740)(19,277)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(26,173)(39,400)(49,504)(29,918)(9,740)(19,277)
Other comprehensive income (loss)     (92)284
Comprehensive loss:(26,173)(39,400)(49,504)(29,918)(9,832)(18,993)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent101(128)(4)(30)  
Comprehensive loss, net of tax, attributable to parent:(26,072)(39,528)(49,508)(29,948)(9,832)(18,993)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: